COLLEGIUM PHARMACEUTICAL, INC. Other Events.
On August 16, 2021, Collegium Pharmaceutical, Inc. (the 'Company') announced that the Board of Directors of the Company authorized the repurchase of up to $100 million of the Company's shares of common stock. The timing and amount of any shares purchased on the open market will be determined based on the Company's evaluation of the market conditions, share price and other factors. The Company plans to utilize existing cash on hand to fund the share repurchase program.
Attachments
- Original document
- Permalink
Disclaimer
Collegium Pharmaceutical Inc. published this content on 16 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 August 2021 12:12:30 UTC.
